Objective: The purpose of the work was to estimate the dose received by the heart throughout a course of breath-holding breast radiotherapy. Methods: 113 cone-beam CT (CBCT) scans were acquired for 20 patients treated within the HeartSpare 1A study, in which both an active breathing control (ABC) device and a voluntary breath-hold (VBH) method were used. Predicted mean heart doses were obtained from treatment plans. CBCT scans were imported into a treatment planning system, heart outlines defined, images registered to the CT planning scan and mean heart dose recorded. Two observers outlined two cases three times each to assess interobserver and intraobserver variation. Results: There were no statistically significant differences between ABC and VBH heart dose data from CT planning scans, or in the CBCT-based estimates of heart dose, and no effect from the order of the breath-hold method. Variation in mean heart dose per fraction over the three imaged fractions was ,6 cGy without setup correction, decreasing to 3.3 cGy with setup correction. If scaled to 15 fractions, all differences between predicted and estimated mean heart doses were ,0.5 Gy and in 80% of cases, they were ,0.25 Gy. Conclusion: Variation in mean heart dose was at an acceptable level over the duration of breath-holding radiotherapy and was well predicted by the planning system. Advances in knowledge: Mean heart dose was not adversely affected by fraction-to-fraction variations throughout a course of heart-sparing radiotherapy using two well-established breath-holding methods.
INTRODUCTION
A reduction in local recurrence and a decrease in mortality result from the use of radiotherapy as a therapeutic agent for breast cancer. 1 Whilst this is a positive effect of radiotherapy, the Early Breast Cancer Trialists' Collaborative Group meta-analysis of 2005 suggests an increase in late non-breast cancer-related mortality associated with radiotherapy, a large component of which is due to cardiovascular disease. 2 More recent evidence suggests that there is no mean heart dose threshold for radiation-related cardiac effects. 3 This evidence has driven efforts to investigate and implement techniques to reduce cardiac radiation exposure whilst maintaining target coverage in breast cancer radiotherapy including intensity-modulated radiotherapy, prone positioning and breathing manoeuvres. [4] [5] [6] Breath-holding is effective in reducing the cardiac radiation dose. [6] [7] [8] The setup reproducibility of breathing control methods is shown to be of the order of 3 mm for both systematic and random error. 8, 9 Electronic portal imaging (EPI) movie loops and EPI dosimetry confirm consistency and stability during radiation delivery. 10, 11 These imply that radiation dose received by the heart is maintained close to the level predicted in the radiotherapy treatment plan. There will be differences in received dose from that predicted as setup and breath-hold variations, although small, do occur fraction to fraction, and often thresholds are used in breast cancer radiotherapy so that setup error is not corrected below an action level. Confirming the impact of these variations on mean heart dose is not trivial, as volumetric imaging information is not available during radiation delivery for most breast radiotherapy treatments. Borst et al 9 and McIntosh et al 12 focused on a detailed comparison of a breathing control method with free breathing, covering aspects such as patient position reproducibility and organ-at-risk doses from treatment plans. Alderliesten et al 13 used heart outline information to derive planning organ-at-risk margins for the heart in cases where surface imaging was used to monitor a breath-hold treatment. In none of these studies were heart dose data estimated throughout the treatment duration or for both equipment-assisted and voluntary breath-hold (VBH) techniques.
This study reports a retrospective analysis of mean heart dose using cone-beam CT (CBCT) images acquired immediately prior to breath-holding breast cancer radiotherapy. The study purpose was to estimate received mean heart dose, to determine any differences between two breath-hold methods and evaluate any variation over the treatment course.
METHODS AND MATERIALS

Patient cohort and imaging data
The data used in this study were obtained from the HeartSpare 1A clinical trial comparing active breathing control (ABC) with VBH. Treatment verification was carried out using megavoltage EPI. In addition, kilovoltage CBCT images were acquired on an Elekta AB (Publ), Stockholm, Sweden X-ray volumetric imaging system 14 on first, third and fifth fractions per breath-hold technique. Data retrieval issues meant 20/23 cases were available with 113 associated CBCT data sets. These were exported to a Philips Radiation Oncology Systems, Madison, Wisconsin, US Pinnacle treatment planning system for rigid registration with the planning CT scan for heart delineation and dose calculation.
Organ delineation
A CBCT image acquisition time of 30 s required two breathholds, which introduced blurring artefacts to the images (the acquisition could not be interrupted during the exposure). The adequacy of the image information for outlining was assessed by visual inspection by two experienced practitioners (a therapeutic radiographer and a clinical oncologist) working with the cardiac outlining guidance of a clinical trial protocol. Both practitioners outlined the heart on one ABC and one VBH scan from the same case three times at 2-week intervals. One practitioner (Observer 1) repeated the sequence of outlining on a second case. All other cases were outlined by Observer 1.
Data and analysis
The heart outlines from the imported CBCT images appeared as structures on the plans used for treatment. Mean heart dose data were collected. The gold standard data were the predicted mean heart dose from the treatment plans using CT planning scans. Estimated doses were expressed as mean heart dose per fraction (in centigray), as only five or six fractions were imaged and this avoided assumptions about the missing data. Heart volumes were recorded for the observer variation study.
Two conditions were considered: the first where it was assumed that no setup correction was made and the second, post-image registration, where all setup errors were assumed to be corrected, i.e. online daily correction. This was achieved by exporting the X-ray volumetric CBCT images so that they were in the same frame of reference as the CT planning scan but without registration data, i.e. in a non-setup correction state. The heart was outlined and dose data were acquired for this condition. Then, rigid registration to the planning CT image was carried out and heart dose data acquired in the corrected position. Data sets were compared (i) between ABC and VBH at pretreatment CT; (ii) between CBCT data for each breath-hold method and the corresponding pre-treatment CT data; (iii) between ABC and VBH CBCT-based data; and (iv) over the treatment duration for each breath-hold technique.
The data were tested for normality using the Shapiro-Wilk test and differences in the means or distributions were tested for statistical significance using an independent-samples two-sided Student's t-test or non-parametric Mann-Whitney U-test as appropriate. The null hypothesis was no statistically significant difference between the means, or the distributions, and a p-value of 0.05 was used as the threshold for statistical significance. Statistical analyses were carried out using IBM SPSS® Statistics v. 22 (IBM Corp., New York, NY; formerly SPSS Inc., Chicago, IL).
RESULTS
Whilst blurring occurred on the CBCT images, both observers were able to outline the heart on the CBCT images. The standard deviation of volumes and mean heart doses from the repeat outlining on the images was taken as a measure of the observer variation: 77 cm 3 (ABC images) and 87 cm 3 (VBH images) for the heart volumes and 2 cGy (both ABC and VBH images) for the corresponding mean heart dose. Absolute volumes were 547 cm 3 (ABC) and 543 cm 3 (VBH) and absolute mean heart doses were 99 cGy (ABC) and 95 cGy (VBH), assuming a 15-fraction treatment. Figure 1 shows mean heart dose per fraction (in centigray) for each case for the ABC (upper panel) and VBH (lower panel) methods, respectively, with and without setup error correction. Correcting the setup error resulted in improvements in the agreement with the gold standard data from the treatment plan and/or reduction in the variation of the mean heart dose values.
As expected, there were no statistically significant differences between ABC and VBH techniques in the mean heart dose data prediction based on CT planning scans. There were no statistically significant differences in the estimated mean heart dose per fraction between the outlines based on the CBCT scans and those predicted for the corresponding CT-based treatment plans for either breath-hold technique. Neither was there a statistically significant difference in estimated heart doses received between the two breath-hold methods. There appeared no effect from the order of breath-hold method (whether the patient started with ABC or VBH). Variations from the expected mean heart dose per fraction from the imaged fraction data were ,6 cGy, with 16/20 of cases showing changes of 2 cGy or less when online correction of setup error was applied. Tables 1 and 2 summarizes the data from the acquired imaging for both ABC and VBH. In addition, data are scaled to 15 fractions assuming the variation from the 3 imaged fractions represents the variation over all fractions. These data are provided to give context to the results with respect to the heart dose expected from completed treatments in breath-hold. 
DISCUSSION
This work has shown that the radiation dose to the heart received by patients throughout a course of breath-holding radiotherapy for breast cancer is not statistical significantly different from that predicted, is not affected by the breathholding techniques investigated and varies by ,0.25 Gy over the whole treatment for the majority of cases.
Neither this work nor that of Borst et al 9 and McIntosh et al 12 was able to obtain volumetric data during each fraction of treatment directly, which would enable a more accurate determination of received heart dose. However, all three studies show a similar pattern-estimates of cardiac dose with breathholding during treatment agree well with those predicted. The reproducibility of breath-hold methods is similar, or better, than generally reported values for free breathing. 8, 9 EPI dosimetry and cine, or movie loop, data have been reported and demonstrated good consistency and stability within fractions and throughout the radiotherapy episode. 10, 11 It was thus likely that doses received by the heart during treatment would be close to those predicted from the CT planning study. This work has enabled quantification of that agreement and in 80% of cases, the differences were no .0.25 Gy with none .0.5 Gy. A decrease in heart dose up to 50% (1.0-2.0 Gy typically) is achieved when using a breath-hold technique compared with free breathing.
9,12
The fraction-to-fraction variations found in this study do not negate this improvement from the use of breath-holding radiotherapy. In addition, our study showed that good agreement was observed for both the ABC method and the VBH technique and was maintained throughout the course of 15 fractions of treatment. This is reassuring for those already offering breathholding treatments to patients and those intending to do so.
Borst et al 9 and McIntosh et al 12 evaluated metrics such as maximum dose to the heart and data for the left descending coronary artery. We selected mean heart dose, as the Darby et al 3 work demonstrated this to be a meaningful metric to enable an individualized cardiac risk for a female requiring breast radiotherapy. The quality of the CBCT images meant that whilst it was possible to contour the heart, outlining small-scale structures such as the left descending coronary artery was not possible. Hardware improvements to the CBCT system, which allow gating, will improve image quality which will assist image registration and outlining. Our work, and that of Lorenzen et al, 15 show that mean heart dose is not sensitive to large changes in heart volume. If we were to repeat this study with a gated CBCT, it is unlikely that different results and conclusions would be obtained even with changed heart outlines.
CONCLUSION
Estimates of the mean heart dose received by patients undergoing a course of breast cancer radiotherapy varied little over the treatment duration for two validated, consistent and stable breath-holding techniques. Bold values indicate a change .0.25 Gy.
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